A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal Cancer
Clinical trial NCT06717880 · RECRUITING
Trial details
- NCT number
- NCT06717880
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-28
- Primary completion
- 2025-07-31
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.